Localized Expertise with a Global Perspective
Benchmark is uniquely positioned to bring technology platforms to market around the world. Our global assistance to clients gives them the advantage they need to reach their market goals. We currently work with established pharmaceutical (both human and animal), as well as new and emerging firms around the world. Providing leading edge research and support; including traditional vaccines, DNA vaccines, unique adjuvants and delivery systems, current influenza antigens (Novel H1N1, H5N1,…) , support for unique platforms (adenovirus, insect cell, plant cell, …), as well as regulatory assistance for licensing and product approval. Whether it be cutting edge influenza research in our select agent approved BSL-3 facility, or pioneering plant-derived vaccine development with the world's first licensed product and facility, Benchmark Biolabs leads the way. From Concept to CommercializationOver the past decade, Benchmark Biolabs has served as the link between the biological discovery and the commercial product. Our experienced staff has provided its clients with a full range of scalable services; focused on the validation, development, licensure, and commercialization of their unique technologies. Benchmark Biolabs is focused on providing the highest quality, most responsive, and most adaptable service to our customers at any point on the path from concept to commercialization. |
Benchmark Biolabs, Inc. | 421 W. Industrial Lake Dr., Lincoln, NE, 68528 | Phone: 402-475-8104 | Fax: 402-475-8511
Copyright © Benchmark Biolabs, Inc. All rights reserved.